These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1785 related articles for article (PubMed ID: 11886323)

  • 81. Does myectomy convey survival benefit in hypertrophic cardiomyopathy?
    Woo A; Rakowski H
    Heart Fail Clin; 2007 Jul; 3(3):275-88. PubMed ID: 17723936
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The Portuguese Registry of Hypertrophic Cardiomyopathy: Overall results.
    Cardim N; Brito D; Rocha Lopes L; Freitas A; Araújo C; Belo A; Gonçalves L; Mimoso J; Olivotto I; Elliott P; Madeira H;
    Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):1-10. PubMed ID: 29358015
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
    Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
    Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Molecular genetics in hypertrophic cardiomyopathy: towards individualized management of the disease.
    Charron P; Komajda M
    Expert Rev Mol Diagn; 2006 Jan; 6(1):65-78. PubMed ID: 16359268
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hypertrophic cardiomyopathy: etiology, diagnosis, and treatment.
    Ramaraj R
    Cardiol Rev; 2008; 16(4):172-80. PubMed ID: 18562807
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
    Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
    Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
    Adamczak DM; Oko-Sarnowska Z
    Cardiol Rev; 2018; 26(3):145-151. PubMed ID: 29621050
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Genetic basis of hypertrophic cardiomyopathy.
    Lind JM; Chiu C; Semsarian C
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):927-34. PubMed ID: 17173506
    [TBL] [Abstract][Full Text] [Related]  

  • 90. New perspectives on the prevalence of hypertrophic cardiomyopathy.
    Semsarian C; Ingles J; Maron MS; Maron BJ
    J Am Coll Cardiol; 2015 Mar; 65(12):1249-1254. PubMed ID: 25814232
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy.
    Rowin EJ; Maron MS; Wells S; Patel PP; Koethe BC; Maron BJ
    J Am Heart Assoc; 2019 Nov; 8(21):e012041. PubMed ID: 31663408
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy.
    Gartzonikas IK; Naka KK; Anastasakis A
    Hellenic J Cardiol; 2023; 70():65-74. PubMed ID: 36403865
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hypertrophic cardiomyopathy--state of the art in 2007.
    Monteiro S; Costa S; Monteiro P; Gonçalves L; Providência LA
    Rev Port Cardiol; 2008 May; 27(5):625-37. PubMed ID: 18717215
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.
    Olivotto I; Cecchi F; Casey SA; Dolara A; Traverse JH; Maron BJ
    Circulation; 2001 Nov; 104(21):2517-24. PubMed ID: 11714644
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment.
    Makavos G; Κairis C; Tselegkidi ME; Karamitsos T; Rigopoulos AG; Noutsias M; Ikonomidis I
    Heart Fail Rev; 2019 Jul; 24(4):439-459. PubMed ID: 30852773
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Obstructive sleep apnea and hypertrophic cardiomyopathy: a common and potential harmful combination.
    Nerbass FB; Pedrosa RP; Danzi-Soares NJ; Drager LF; Arteaga-Fernández E; Lorenzi-Filho G
    Sleep Med Rev; 2013 Jun; 17(3):201-6. PubMed ID: 23046848
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Romanian Registry of Hypertrophic Cardiomyopathy - overview of general characteristics and therapeutic choices at a national level.
    Ionilă P; Jurcuţ R; Ferariu N; Roşca M; Chivulescu M; Mursă A; Militaru S; Ionescu AA; Căldăraru C; Fruntelată AG; Goanţă SF; Crişan S; Ionac A; Avram AM; Frigy A; Sascău R; Arsenescu-Georgescu C; Coman IM; Popescu BA; Ginghină C; Apetrei E
    Rom J Intern Med; 2018 Sep; 56(3):203-209. PubMed ID: 29791317
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Surgery for hypertrophic cardiomyopathy.
    Wu JJ; Seco M; Medi C; Semsarian C; Richmond DR; Dearani JA; Schaff HV; Byrom MJ; Bannon PG
    Biophys Rev; 2015 Mar; 7(1):117-125. PubMed ID: 28509978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 90.